Short Interest in Nexien BioPharma, Inc. (OTCMKTS:NXEN) Drops By 16.7%

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the target of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 500 shares, a decline of 16.7% from the October 31st total of 600 shares. Based on an average daily trading volume, of 40,000 shares, the short-interest ratio is presently 0.0 days.

Nexien BioPharma Trading Up 8.5 %

NXEN stock opened at $0.01 on Monday. Nexien BioPharma has a 1-year low of $0.01 and a 1-year high of $0.05. The firm has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.02.

About Nexien BioPharma

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.